Webinar May 22nd 2025 Helena Aicher: Psychedelic therapy – refining the claim of a paradigm shift

The evolving role of psychedelics in mental health treatment is often referred to as the “psychedelic renaissance” or even a “paradigm shift” in psychiatry. But does this resurgence truly represent a revolutionary change, might it be better understood as an integration of existing therapeutic approaches and perspectives?

On Thursday May 22nd at 6PM (UTC+3), in a webinar lecture organized by the Finnish Association for Psychedelic Research, will dig into this question with Swiss postdoctoral researcher Helena Aicher. The discussion will highlight both the novel and familiar aspects of psychedelic treatments in comparison to traditional therapies. Emphasizing a balanced, bio-psycho-social model, we’ll consider how psychedelics can enhance, rather than replace, existing psychiatric frameworks, advocating for a more nuanced understanding of their place within modern mental health care.

The event contains a Q&A section and the total length is 2 hours. 

We offer this webinar as a pay what you can event: you can participate without paying, but by paying, you can help us produce more events like this and ensure that we can keep offering them to people regardless of their financial circumstances.

0 € – register here
5 € – buy ticket here
10 € – buy ticket here

20 € – buy ticket here

If you pay for the ticket, please also remember to register for the webinar via the registration link!

You can also support us by paying our membership fee for 2025. You’ll find our membership products on the main page of our web store. We also accept donations. 

About the speaker:

Postdoctoral researcher at the Universities of Zürich and Basel. Helena is involved in several trials investigating psychedelics, mechanisms, and contextual factors. She also works as a psychotherapist including the limited medical use of psychedelics. With her engagement in the Swiss Medical Association for Psychedelic Therapy (SÄPT) she’s involved as a trainer in psychedelic therapist trainings. Helena bridges science and practice, contributing to the development and implementation of psychedelic-assisted therapy.